Day: February 10, 2025

NXP Agrees to Acquire Edge AI Pioneer Kinara to Redefine the Intelligent Edge

Written by Customer Service on February 10, 2025. Posted in Mergers And Acquisitions.

NXP Agrees to Acquire Edge AI Pioneer Kinara to Redefine the Intelligent EdgeNXP Semiconductors has entered into a definitive agreement to acquire Kinara, Inc., an industry leader in high performance, energy-efficient and programmable discrete NPUsEnhances NXP’s leading processing portfolio with cutting edge NPUs and AI software, driving intelligent system solutions across the industrial and automotive edge markets. Delivers high-performance neural network processing with advanced generative AI to create transformative edge use cases. Establishes a scalable platform for AI-powered edge systems, combining NXP’s broad portfolio of processing, connectivity, security, and advanced analog solutions, with Kinara’s AI hardware and software.EINDHOVEN, the Netherlands, Feb. 10, 2025 (GLOBE NEWSWIRE) — NXP Semiconductors...

GCM Grosvenor Reports Fourth Quarter and Full Year 2024 Earnings Results, with 2024 Fundraising Increasing 41%, and Year-to-Date GAAP Net Income, Fee-Related Earnings and Adjusted Net Income Increasing 46%, 19% and 36%, Respectively, Year-Over-Year

Written by Customer Service on February 10, 2025. Posted in Dividend Reports And Estimates.

CHICAGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, today reported its results for the fourth quarter and full year December 31, 2024. GCM Grosvenor issued a detailed presentation of its results to the Public Shareholders section of GCM Grosvenor’s website at https://www.gcmgrosvenor.com/shareholder-events. GCM Grosvenor’s Board of Directors approved a $0.11 per share dividend payable on March 17, 2025 to shareholders on record March 3, 2025. In addition, in February 2025, GCM Grosvenor’s Board of Directors increased the firm’s existing share repurchase authorization by $50 million, from $140 million to $190 million. Conference Call A conference call to discuss GCM Grosvenor’s financial results will be held today, Monday, February 10,...

DMC Global Acknowledges Non-Binding Proposal from Steel Connect

Written by Customer Service on February 10, 2025. Posted in Mergers And Acquisitions.

BROOMFIELD, Colo., Feb. 10, 2025 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) (“DMC” or the “Company”) today acknowledged receipt of a non-binding proposal from Steel Connect to acquire all of the outstanding shares of common stock of the Company, not already owned by Steel Connect, for $10.18 per share in cash (the “Proposal”). DMC’s board of directors (the “Board”) will consider the Proposal in consultation with its legal and financial advisors and in accordance with its fiduciary duties. In the meantime, stockholders need not take any action. The Proposal is subject to further due diligence by Steel Connect. There can be no assurance that any definitive agreement will be executed, or that the Proposal or any other transaction will be approved or consummated. The Company will have no further comment on the Proposal until...

Tower Semiconductor Reports 2024 Fourth Quarter and Full Year Financial Results

Written by Customer Service on February 10, 2025. Posted in Earnings Releases And Operating Results.

MIGDAL HAEMEK, Israel, Feb. 10, 2025 (GLOBE NEWSWIRE) — Tower Semiconductor (NASDAQ: TSEM & TASE: TSEM) reports today its results for the fourth quarter of 2024 and for the year ended December 31, 2024. Fourth Quarter of 2024 Results OverviewRevenues for the fourth quarter of 2024 were $387 million as compared to $371 million for the third quarter of 2024 and $352 million for the fourth quarter of 2023, representing 5% quarter over quarter growth and 10% year over year growth. The Company met its expressed target of sequential quarter over quarter revenue growth within 2024, resulting in 18% growth fourth quarter over first quarter. Gross profit for the fourth quarter of 2024 was $87 million, compared to $84 million for the fourth quarter of 2023. During the fourth quarter of 2024, the Company took on for the first time its...

Hain Celestial Reports Fiscal Second Quarter 2025 Financial Results

Written by Customer Service on February 10, 2025. Posted in Earnings Releases And Operating Results.

Strong Operating Cash Flow and Reduction in Debt; Positioned to Pivot to Growth in Back HalfExploring Strategic Options for Personal Care Category HOBOKEN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) — Hain Celestial Group (Nasdaq: HAIN), a leading global health and wellness company whose purpose is to inspire healthier living through better-for-you brands, today reported financial results for its fiscal second quarter ended December 31, 2024. “Despite challenges in the quarter, we generated strong operating cash flow and further reduced debt. We drove sequential improvement in baby & kids and in our largest category, meal prep. However, sales growth in the quarter was hindered by poor in-store performance in snacks, driven by marketing and promotion effectiveness, and supply chain challenges, both of which we have already taken...

Roivant Reports Financial Results for the Third Quarter Ended December 31, 2024, and Provides Business Update

Written by Customer Service on February 10, 2025. Posted in Earnings Releases And Operating Results.

BASEL, Switzerland and LONDON and NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) — Roivant (Nasdaq: ROIV) today reported its financial results for the third quarter ended December 31, 2024, and provided a business update.Brepocitinib to be developed in third indication, cutaneous sarcoidosis (CS), an orphan indication with high unmet need; Phase 2 study initiation expected in second quarter of calendar year with topline data in second half of calendar year 2026 IMVT-1402 development is rapidly progressing with six Investigational New Drug (IND) applications cleared and pivotal studies in Graves’ disease (GD) and difficult-to-treat rheumatoid arthritis (D2T RA) initiated Batoclimab topline results from pivotal trial in myasthenia gravis (MG) and initial results from period 1 of trial in chronic inflammatory demyelinating polyneuropathy...

Alterity Therapeutics Raises A$40.0 million in Placement

Written by Customer Service on February 10, 2025. Posted in Public Companies.

– Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders – – Capital raising was strongly supported by domestic and international institutional investors – MELBOURNE, Australia and SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or the “Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced it has received binding commitments for a capital raising of A$40.0 million via a two tranche placement (the “Placement”) of fully paid ordinary shares (“New Shares”) to Australian and international institutions and other unrelated sophisticated, professional or exempt investors. “We are grateful for the strong response from the investment community and are proud to welcome...

Join Can-Fite’s Exclusive Live Investor Webinar and Q&A Session on February 25

Written by Customer Service on February 10, 2025. Posted in Public Companies.

RAMAT GAN, Israel, Feb. 10, 2025 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, invites investors to a webinar on Tuesday, February 25, 2025, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Companies, will feature Can-Fite Chief Executive Officer Motti Farbstein and Executive Chairperson and Chief Scientific Officer Dr. Pnina Fishman, who will share insight into the Company’s current development pipeline and upcoming milestones. Strategically positioned with multiple out-licensing deals and potential regulatory and sales milestone payments totaling over $130 million, Can-Fite has already received $20 million in upfront and milestone payments, underscoring...

Goliath Drills Intrusive Feeder Assaying 12.03 g/t AuEq Over 10.00 Meters Including 19.91 g/t AuEq Over 6.00 Meters And Discovers Five New Stacked Gold Veins That Remain Open Confirming An Extensive Gold Rich Source At Depth On Surebet, Golden Triangle, B.C.

Written by Customer Service on February 10, 2025. Posted in Public Companies.

Assays Compilation, Interpretation and Modeling For 83 More Holes Are UnderwayInfographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4Infographic 5Infographic 5Infographic 6Infographic 6Infographic 7Infographic 7Infographic 8Infographic 8Infographic 9Infographic 9Drilling Highlights:Strong gold mineralization assaying 12.03 g/t AuEq (11.84 g/t Au and 15.61 g/t Ag) over 10.00 meters, including 19.91 g/t AuEq (19.62 g/t Au and 25.61 g/t Ag) over 6.00 meters plus a second separate interval assaying 8.59 g/t AuEq (8.35 g/t Au and 20.74 g/t Ag) over 5.00 meters, including 14.26 g/t AuEq (13.87 g/t Au and 34.10 g/t Ag) over 3.00 meters have been confirmed in an intrusion related feeder dyke that remains open, strongly...

Kraig Biocraft Laboratories Unveils Groundbreaking Scientific Achievement Based on Caddisfly Silk Proteins

Written by Customer Service on February 10, 2025. Posted in Public Companies.

Successfully creates transgenic based on underwater adhesive properties of Caddisfly ANN ARBOR, Mich., Feb. 10, 2025 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), a leading developer of spider silk-based fibers, proudly announces the successful creation of new novel silk, build upon the silk proteins of the remarkable caddisfly. This breakthrough marks a new frontier in the field of engineered fibers and underscores the Company’s commitment to pioneering innovations in biotechnology.Caddisflies (known in the Pacific Northwest as “Periwinkles”) are known for their extraordinary ability to spin silk underwater, which they use to construct protective cases in aquatic environments. By leveraging the unique mechanical and chemical attributes...

Day: February 10, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals